Multi-institutional study of Osimertinib dose-optimization in Non-small cell lung cancer patients with EGFR activating mutation aged 70 Years or older - Multi-institutional study of Osimertinib dose-optimization in Non-small cell lung cancer patients with EGFR activating mutation aged 70 Years or older(MONEY Trial)
/ RecruitingNot ApplicableIIT Cohort Study to Evaluate the Efficacy and Safety of Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer Patients with Muti-gene assay - N-SAS BC07 biomarker study (Trans-RESPECT)
/ CompletedNot ApplicableIIT An assessment of quality of life using electronic patient-reported outcome (ePRO) in patients receiving second-line chemotherapy for unresectable pancreatic cancer - QOL-ePAC
100 Clinical Results associated with Public Health Research Foundation
0 Patents (Medical) associated with Public Health Research Foundation
100 Deals associated with Public Health Research Foundation
100 Translational Medicine associated with Public Health Research Foundation